We are live on
!
Find out more
VLC
Van Leeuwen & Company Portfolio holdings
AUM
$197M
1-Year Est. Return
44.16%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+44.16%
3 Year Est. Return
+75.42%
5 Year Est. Return
+199.79%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$4.3M
(+3%)
Cap. Flow
-$3.37M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
43.21%
Holding
84
New
18
Increased
28
Reduced
23
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.5M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$3.37M |
| 3 |
AbbVie
ABBV
|
+$2.93M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.65M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$10.5M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$5.91M |
| 3 |
Pfizer
PFE
|
+$5.04M |
| 4 |
Elevance Health
ELV
|
+$3.65M |
| 5 |
MRSH
Marsh
MRSH
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Financials | 11.81% |
| 5 | Communication Services | 10.02% |
Similar funds
SXM
BG
DAM
CC
CWMU
EA
HI
CC
Van Leeuwen & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Van Leeuwen & Company held 84 positions worth $149M, up 3% from $145M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Van Leeuwen & Company's Q1 2023 filing shows 18 new, 28 increased, 23 reduced and 12 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 85,808 shares worth $3.47M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $10.5M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Van Leeuwen & Company's largest Q1 2023 buy was Vanguard FTSE Emerging Markets ETF: 85,808 shares worth $3.47M.
- Van Leeuwen & Company added most to iShares MSCI EAFE ETF in Q1 2023, an estimated $3.37M increase.
- Van Leeuwen & Company's biggest Q1 2023 reduction was Merck, cutting an estimated $1.32M.
- Van Leeuwen & Company fully exited Invesco S&P 500 Equal Weight ETF in Q1 2023, selling an estimated $10.5M.
- Van Leeuwen & Company's ten largest holdings make up 43% of its $149M portfolio in Q1 2023.
- Van Leeuwen & Company opened 18 new positions and closed 12 in Q1 2023.
- Van Leeuwen & Company's portfolio value rose 3% quarter-over-quarter to $149M.
Based on Van Leeuwen & Company's 13F filing for Q1 2023, filed 8 May 2023.